Lotus Pharmaceutical Co., Ltd. Warrant (061355)
Market Closed
22 Jul, 05:30
TWSE TWSE Primary NT$
2. 72
-2.02
-42.616%
NT$
- Market Cap
- P/E Ratio
- Div Yield
8,000 Volume
- Eps
NT$ 4.74
Previous Close Want to track 061355 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
061355 closed Wednesday lower at NT$2.72, a decrease of -42.616% from Tuesday's close, completing a monthly increase of 0% or NT$0. Over the past 12 months, 061355 stock gained 63.8554%.
061355 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.
061355 Chart
Lotus Pharmaceutical Co., Ltd. Warrant (061355) FAQ
What is the stock price today?
The current price is NT$2.72.
On which exchange is it traded?
Lotus Pharmaceutical Co., Ltd. Warrant is listed on TWSE.
What is its stock symbol?
The ticker symbol is 061355.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Lotus Pharmaceutical Co., Ltd. Warrant ever had a stock split?
No, there has never been a stock split.
Lotus Pharmaceutical Co., Ltd. Warrant Profile
| - Industry | - Sector | - CEO | TWSE Exchange | - ISIN |
| Taiwan Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Lotus Pharmaceutical Co., Ltd. Warrant represents a derivative security that grants the holder the right, but not the obligation, to purchase shares of Lotus Pharmaceutical Co., Ltd. within a specified time period at a predetermined price. Warrants like these are used by companies to raise capital or as part of strategic financial management. Lotus Pharmaceutical is a prominent player in the pharmaceutical industry, focusing on the development, manufacture, and distribution of generic medications and specialty drugs across various therapeutic areas. The warrant provides investors with the opportunity to participate in the potential future growth of Lotus Pharmaceutical without the immediate outlay of equity capital. These instruments are vital in allowing investors leveraged exposure to the company’s equity, impacting sectors like healthcare, biotechnology, and pharmaceuticals. As a market tool, this warrant enhances the liquidity of Lotus Pharmaceutical’s shares and broadens the investor base by attracting those interested in the underlying company’s strategic developments in the healthcare industry.
Contact Information
Address: -
Phone: -
